Cargando…
Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
The TP53 gene encodes the transcription factor and oncosuppressor p53 protein that regulates a multitude of intracellular metabolic pathways involved in DNA damage repair, cell cycle arrest, apoptosis, and senescence. In many cases, alterations (e.g., mutations of the TP53 gene) negatively affect th...
Autores principales: | Mirgayazova, Regina, Khadiullina, Raniya, Chasov, Vitaly, Mingaleeva, Rimma, Miftakhova, Regina, Rizvanov, Albert, Bulatov, Emil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349023/ https://www.ncbi.nlm.nih.gov/pubmed/32630614 http://dx.doi.org/10.3390/genes11060704 |
Ejemplares similares
-
Novel Isatin-based activator of p53 transcriptional functions in tumor cells
por: Mirgayazova, Regina, et al.
Publicado: (2019) -
Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy
por: Chasov, Vitaly, et al.
Publicado: (2020) -
Assessment of Thermal Stability of Mutant p53 Proteins via Differential Scanning Fluorimetry
por: Khadiullina, Raniya, et al.
Publicado: (2022) -
Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies
por: Chasov, Vitaly, et al.
Publicado: (2021) -
Adipose-Derived Mesenchymal Stem Cell (MSC) Immortalization by Modulation of hTERT and TP53 Expression Levels
por: Rakhmatullina, Aigul R., et al.
Publicado: (2023)